18 and older, any sex, with Anxiety Depression. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Completion RateSecondary· 12 weeks
Out of the 20 participants in each clinical trial arm, this outcome reflects the number of participants who completed the engagement component by Week 12 of the intervention.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
15
Individual Teletherapy (IT)
17
Engagement (8-item Scale)Primary· Week 4
Participant engagement was assessed using a self-report engagement measure administered at post-intervention. Items were rated on a 5-point Likert-type scale ranging from 1 to 5, with higher scores indicating greater engagement. Mean engagement scores are reported as scores on a scale.
Engagement scores represent the mean of all item responses, yielding a possible score range from 1 to 5.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
3.90
± .12
Individual Teletherapy (IT)
4.62
± .12
Engagement (8-item Scale)Primary· Week 8
Participant engagement was assessed using a self-report engagement measure administered at post-intervention. Items were rated on a 5-point Likert-type scale ranging from 1 to 5, with higher scores indicating greater engagement. Mean engagement scores are reported as scores on a scale.
Engagement scores represent the mean of all item responses, yielding a possible score range from 1 to 5.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
4.11
± .12
Individual Teletherapy (IT)
4.70
± .12
Engagement (8-item Scale)Primary· Week 12
Participant engagement was assessed using a self-report engagement measure administered at post-intervention. Items were rated on a 5-point Likert-type scale ranging from 1 to 5, with higher scores indicating greater engagement. Mean engagement scores are reported as scores on a scale.
Engagement scores represent the mean of all item responses, yielding a possible score range from 1 to 5.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
3.74
± .12
Individual Teletherapy (IT)
4.79
± .12
Anxiety Symptoms (GAD-7)Primary· Week 12
Anxiety symptoms were assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7). Items are rated on a 4-point scale ranging from 0 ("not at all") to 3 ("nearly every day"). Item responses are summed to compute a total score. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
14.91
± 1.12
Individual Teletherapy (IT)
11.69
± 1.19
Anxiety Symptoms (GAD-7)Primary· Week 8
Anxiety symptoms were assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7). Items are rated on a 4-point scale ranging from 0 ("not at all") to 3 ("nearly every day"). Item responses are summed to compute a total score. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
13.79
± 1.12
Individual Teletherapy (IT)
13.23
± 1.19
User Feedback SentimentSecondary· Week 4
Sentiment was quantified using a continuous sentiment score ranging from 0 to 1, with higher values indicating more positive sentiment. Sentiment scores were derived from open-ended responses collected at Week 4. Due to non-normal distributions, sentiment scores are summarized using medians and interquartile ranges and are reported as scores on a scale.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
0.134
0.044 – 0.170
Individual Teletherapy (IT)
0.217
0.100 – 0.365
User Feedback SentimentSecondary· Week 8
Sentiment was quantified using a continuous sentiment score ranging from 0 to 1, with higher values indicating more positive sentiment. Sentiment scores were derived from open-ended responses collected at Week 8. Due to non-normal distributions, sentiment scores are summarized using medians and interquartile ranges and are reported as scores on a scale.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
0.38
0.18 – 0.56
Individual Teletherapy (IT)
0.45
0.26 – 0.63
User Feedback SentimentSecondary· Week 12
Sentiment was quantified using a continuous sentiment score ranging from 0 to 1, with higher values indicating more positive sentiment. Sentiment scores were derived from open-ended responses collected at Week 12. Due to non-normal distributions, sentiment scores are summarized using medians and interquartile ranges and are reported as scores on a scale.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
0.39
0.281 – 0.476
Individual Teletherapy (IT)
0.393
0.255 – 0.476
Anxiety Symptoms (GAD-7)Primary· Week 4
Anxiety symptoms were assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7). Items are rated on a 4-point scale ranging from 0 ("not at all") to 3 ("nearly every day"). Item responses are summed to compute a total score. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
13.09
± 1.19
Individual Teletherapy (IT)
13.02
± 1.19
Anxiety Symptoms (GAD-7)Primary· Baseline
Anxiety symptoms were assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7). Items are rated on a 4-point scale ranging from 0 ("not at all") to 3 ("nearly every day"). Item responses are summed to compute a total score. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
10.01
± 0.98
Individual Teletherapy (IT)
8.96
± 1.05
Depressive Symptoms (PHQ-9)Primary· Baseline
Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item self-report measure. Items are rated on a 4-point scale ranging from 0 ("not at all") to 3 ("nearly every day"). Item responses are summed to compute a total score. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.
Group
Value
95% CI
Guided Group Therapy (GGT) Via TheraGroup
10.62
± 0.99
Individual Teletherapy (IT)
9.90
± 1.08
Sponsor's own description
The goal of this study is to address the mental health crisis among college students by creating a promising solution for group teletherapy, which is equivalent to individual teletherapy in terms of treatment outcomes.The main question it aims to answer is: if participants' outcome measures in TheraGroup are in line with participants' outcome measures in individual therapy. The goal of the current SBIR is to test TheraGroup, the first large scale virtual group platform for evidenced-based mental health therapy. The TheraGroup application addresses the market surge in the demand for care and the shortage of mental health professionals as it represents an economically viable treatment alternative to individual teletherapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Veronica Tetterton
Last refreshed: 23 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07237217.